TY - JOUR AU - Rena, O. AU - Oliaro, A. AU - Cavallo, A. AU - Filosso, P. L. AU - Donati, G. AU - Marzo, P. PY - 2002 DA - 2002// TI - Stage I non-small cell lung carcinoma: really an early stage? JO - Eur J Cardiothorac Surg VL - 21 UR - https://doi.org/10.1016/S1010-7940(01)01153-8 DO - 10.1016/S1010-7940(01)01153-8 ID - Rena2002 ER - TY - JOUR AU - Rosell, R. AU - Bivona, T. G. AU - Karachaliou, N. PY - 2013 DA - 2013// TI - Genetics and biomarkers in personalisation of lung cancer treatment JO - Lancet VL - 382 UR - https://doi.org/10.1016/S0140-6736(13)61715-8 DO - 10.1016/S0140-6736(13)61715-8 ID - Rosell2013 ER - TY - JOUR AU - Pardoll, D. M. PY - 2012 DA - 2012// TI - The blockade of immune checkpoints in cancer immunotherapy JO - Nat Rev Cancer VL - 12 UR - https://doi.org/10.1038/nrc3239 DO - 10.1038/nrc3239 ID - Pardoll2012 ER - TY - JOUR AU - Brahmer, J. AU - Reckamp, K. L. AU - Baas, P. AU - Crino, L. AU - Eberhardt, W. E. AU - Poddubskaya, E. PY - 2015 DA - 2015// TI - Nivolumab versus docetaxel in advanced nonsquamous non-small-cell lung Cancer JO - N Engl J Med VL - 373 UR - https://doi.org/10.1056/NEJMoa1504627 DO - 10.1056/NEJMoa1504627 ID - Brahmer2015 ER - TY - JOUR AU - Herbst, R. S. AU - Baas, P. AU - Kim, D. W. AU - Felip, E. AU - Perez-Gracia, J. L. AU - Han, J. Y. PY - 2016 DA - 2016// TI - Pembrolizumab versus docetaxel for previously treated, PD-L1-positive, advanced non-small-cell lung cancer (KEYNOTE-010): a randomised controlled trial JO - Lancet. VL - 387 UR - https://doi.org/10.1016/S0140-6736(15)01281-7 DO - 10.1016/S0140-6736(15)01281-7 ID - Herbst2016 ER - TY - JOUR AU - Rittmeyer, A. AU - Barlesi, F. AU - Waterkamp, D. AU - Park, K. AU - Ciardiello, F. AU - Pawel, J. PY - 2017 DA - 2017// TI - Atezolizumab versus docetaxel in patients with previously treated non-small-cell lung cancer (OAK): a phase 3, open-label, multicentre randomised controlled trial JO - Lancet. VL - 389 UR - https://doi.org/10.1016/S0140-6736(16)32517-X DO - 10.1016/S0140-6736(16)32517-X ID - Rittmeyer2017 ER - TY - JOUR AU - Johnson, G. L. AU - Lapadat, R. PY - 2002 DA - 2002// TI - Mitogen activated protein kinase pathways mediated by ERK, JNK and p38 protein kinases JO - Science. VL - 298 UR - https://doi.org/10.1126/science.1072682 DO - 10.1126/science.1072682 ID - Johnson2002 ER - TY - JOUR AU - Roberts, P. J. AU - Der, C. J. PY - 2007 DA - 2007// TI - Targeting the Raf-MEK-ERK mitogen-activated protein kinase cascade for the treatment of cancer JO - Oncogene. VL - 26 UR - https://doi.org/10.1038/sj.onc.1210422 DO - 10.1038/sj.onc.1210422 ID - Roberts2007 ER - TY - JOUR AU - Cooper, Z. A. AU - Reuben, A. AU - Austin-Breneman, J. AU - Wargo, J. A. PY - 2015 DA - 2015// TI - Does it MEK a difference? Understanding immune effects of targeted therapy JO - Clin Cancer Res VL - 21 UR - https://doi.org/10.1158/1078-0432.CCR-15-0363 DO - 10.1158/1078-0432.CCR-15-0363 ID - Cooper2015 ER - TY - JOUR AU - Liu, I. AU - Mayes, P. A. AU - Eastman, S. AU - Shi, H. AU - Yadavilli, S. AU - Zhang, T. PY - 2015 DA - 2015// TI - The BRAF and MEK inhibitors dabrafenib and trametinib: effects on immune function and ombination with immunomodulatory antibodies targeting PD-1, PD-L1, and CTLA-4 JO - Clin Cancer Res VL - 21 UR - https://doi.org/10.1158/1078-0432.CCR-14-2339 DO - 10.1158/1078-0432.CCR-14-2339 ID - Liu2015 ER - TY - JOUR AU - Kakavand, H. AU - Wilmott, J. S. AU - Menziew, A. M. AU - Vilain, R. AU - Haydu, L. E. AU - Yearley, J. H. PY - 2015 DA - 2015// TI - PD-L1 expression and tumor-infiltrating lymphocytes define different subsets of MAPK-inhibitor treated melanoma patients JO - Clin Cancer Res VL - 21 UR - https://doi.org/10.1158/1078-0432.CCR-14-2023 DO - 10.1158/1078-0432.CCR-14-2023 ID - Kakavand2015 ER - TY - JOUR AU - Bancroft, C. C. AU - Chen, Z. AU - Dong, G. AU - Sunwoo, J. B. AU - Yen, N. AU - Park, C. PY - 2001 DA - 2001// TI - Coexpression of proangiogenic factors IL-8 and VEGF by human head and neck squamous cell carcinoma involves coactivation by MEK-MAPK and IKK-NF-kappaB signal pathways JO - Clin Cancer Res VL - 7 ID - Bancroft2001 ER - TY - JOUR AU - Bancroft, C. C. AU - Chen, Z. AU - Yeh, J. AU - Sunwoo, J. B. AU - Yen, N. T. AU - Jackson, S. PY - 2002 DA - 2002// TI - Effects of pharmacologic antagonists of epidermal growth factor receptor, PI3K and MEK signal kinases on NF-kappaB and AP-1 activation and IL-8 and VEGF expression in human head and neck squamous cell carcinoma lines JO - Int J Cancer VL - 99 UR - https://doi.org/10.1002/ijc.10398 DO - 10.1002/ijc.10398 ID - Bancroft2002 ER - TY - JOUR AU - Tsai, J. P. AU - Hsiao, P. C. AU - Yang, S. F. AU - Hsieh, S. C. AU - Bau, D. T. AU - Ling, C. L. PY - 2014 DA - 2014// TI - Licochalcone a suppresses migration and invasion of human hepatocellular carcinoma cells through downregulation of MKK4/JNK via NF-kappaB mediated urokinase plasminogen activator expression JO - PLoS One VL - 22 UR - https://doi.org/10.1371/journal.pone.0086537 DO - 10.1371/journal.pone.0086537 ID - Tsai2014 ER - TY - JOUR AU - Lee, G. Y. AU - Kenny, P. A. AU - Lee, E. H. AU - Bissell, M. J. PY - 2007 DA - 2007// TI - Three-dimensional culture models of normal and malignant breast epithelial cells JO - Nat Methods VL - 4 UR - https://doi.org/10.1038/nmeth1015 DO - 10.1038/nmeth1015 ID - Lee2007 ER - TY - JOUR AU - DeRose, Y. S. AU - Gligorich, K. M. AU - Wang, G. AU - Georgelas, A. AU - Bowman, P. AU - Courdy, S. J. PY - 2013 DA - 2013// TI - Patient-derived models of human breast cancer: protocols for in vitro and in vivo applications in tumor biology and translational medicine JO - Curr Protoc Pharmacol VL - 14 ID - DeRose2013 ER - TY - JOUR AU - Morgillo, F. AU - Cascone, T. AU - D'Aiuto, E. AU - Martinelli, E. AU - Troiani, T. AU - Saintigny, P. PY - 2011 DA - 2011// TI - Antitumour efficacy of MEK inhibitors in human lung cancer cells and their derivatives with acquired resistance to different tyrosine kinase inhibitors JO - Br J Cancer VL - 105 UR - https://doi.org/10.1038/bjc.2011.244 DO - 10.1038/bjc.2011.244 ID - Morgillo2011 ER - TY - JOUR AU - Weeber, F. AU - Wetering, M. AU - Hoogstraat, M. AU - Dijkstra, K. K. AU - Krijgsman, O. AU - Kuilman, T. PY - 2015 DA - 2015// TI - Preserved genetic diversity in organoids cultured from biopsies of human colorectal cancer metastases JO - Proc Natl Acad Sci U S A VL - 112 UR - https://doi.org/10.1073/pnas.1516689112 DO - 10.1073/pnas.1516689112 ID - Weeber2015 ER - TY - JOUR AU - Wetering, M. AU - Francies, H. E. AU - Francis, J. M. AU - Bounova, G. AU - Iorio, F. AU - Pronk, A. PY - 2015 DA - 2015// TI - Prospective derivation of a living organoid biobank of colorectal cancer patients JO - Cell. VL - 161 UR - https://doi.org/10.1016/j.cell.2015.03.053 DO - 10.1016/j.cell.2015.03.053 ID - Wetering2015 ER - TY - JOUR AU - Schütte, M. AU - Risch, T. AU - Abdavi-Azar, N. AU - Boehnke, K. AU - Schumacher, D. AU - Keil, M. PY - 2017 DA - 2017// TI - Molecular dissection of colorectal cancer in pre-clinical models identifies biomarkers predicting sensitivity to EGFR inhibitors JO - Nat Commun VL - 8 UR - https://doi.org/10.1038/ncomms14262 DO - 10.1038/ncomms14262 ID - Schütte2017 ER - TY - JOUR AU - Lastwika, K. J. AU - Wilson, W. AU - Li, Q. K. AU - Norris, J. AU - Xu, H. AU - Ghazarian, S. R. PY - 2016 DA - 2016// TI - Control of PD-L1 expression by oncogenic activation of the AKT-mTOR pathway in non-small cell lung Cancer JO - Cancer Res VL - 76 UR - https://doi.org/10.1158/0008-5472.CAN-14-3362 DO - 10.1158/0008-5472.CAN-14-3362 ID - Lastwika2016 ER - TY - JOUR AU - Chen, N. AU - Fang, W. AU - Lin, Z. AU - Peng, P. AU - Wang, J. AU - Zhan, J. PY - 2017 DA - 2017// TI - KRAS mutation-induced upregulation of PD-L1 mediates immune escape in human lung adenocarcinoma JO - Cancer Immunol Immunother VL - 66 UR - https://doi.org/10.1007/s00262-017-2005-z DO - 10.1007/s00262-017-2005-z ID - Chen2017 ER - TY - JOUR AU - Skoulidis, F. AU - Goldberg, M. E. AU - Greenawalt, D. M. AU - Hellmann, M. D. AU - Awad, M. M. AU - Gainor, J. F. PY - 2018 DA - 2018// TI - STK11/LKB1 Mutations and PD-1 Inhibitor Resistance in KRAS-Mutant Lung Adenocarcinoma JO - Cancer Discov VL - 8 UR - https://doi.org/10.1158/2159-8290.CD-18-0099 DO - 10.1158/2159-8290.CD-18-0099 ID - Skoulidis2018 ER -